8-K: Knowles Corporation Unveils Strategic Plan for Growth at Investor Day 2025

Knowles Corporation outlines its strategic vision for future growth, focusing on high-margin markets and strategic acquisitions, at its Investor Day 2025.

Summary

• Knowles Corporation hosted an investor update meeting on May 13, 2025, presenting its business and financial outlook.
• The company is focused on higher-margin products and markets, specifically MedTech, Defense, and Industrial sectors.
• Knowles aims for an 8-10% revenue CAGR and a 10-14% adjusted EBITDA CAGR over the next five years.
• The company's 2024 revenue was $554 million, with 54% from Precision Devices and 46% from MedTech & Specialty Audio.
• Precision Devices is expected to have a 6-8% organic revenue CAGR from 2024-2029.
• MedTech & Specialty Audio is expected to have a 2-4% organic revenue CAGR from 2024-2029.
• The company is targeting a 16-20% cash from operations as a percentage of revenue.
• Knowles anticipates full-year 2025 revenue between $560-$590 million and adjusted EBITDA between $140-$150 million.
• The company plans to deploy capital with a targeted return of 200-300 bps above the cost of capital.
• Knowles has an existing liquidity of over $350 million to support acquisition growth.

Sentiment

Score: 8

Explanation: The document presents a positive outlook with clear growth targets, a strong balance sheet, and a focus on high-margin markets. The company's strategic transformation and proven M&A strategy contribute to a favorable sentiment.

Positives

• Knowles is focused on high-margin markets like MedTech, Defense, and Industrial.
• The company has a strong balance sheet and robust cash generation.
• Knowles has a proven M&A strategy to supplement organic growth.
• The company is experiencing margin expansion through lean manufacturing, automation, and cost control.
• Knowles has a differentiated position through customization at scale, creating a competitive advantage.
• The company has an additional $150M share repurchase program authorized by the BOD.

Risks

• The presentation contains forward-looking statements that are subject to risks and uncertainties.
• These risks include global economic instability, fluctuations in operating results, and increasing competition.
• The company's ability to achieve strategic and financial benefits from acquisitions is not guaranteed.
• Cybersecurity incidents and disruptions in the supply chain could negatively impact the company.
• Escalating international trade tensions and changes in tax laws could pose financial risks.

Future Outlook

Knowles projects an 8-10% revenue CAGR and a 10-14% adjusted EBITDA CAGR over the next five years, with full-year 2025 revenue between $560-$590 million and adjusted EBITDA between $140-$150 million.

Management Comments

• Knowles is enabling innovation that moves the world forward.
• The company is creating value for its organization, customers, and shareholders today and in the future.
• Knowles is strategically focused on expanding from its strong core.

Industry Context

Knowles is positioning itself as an industrial technology leader, focusing on high-growth markets like MedTech, Defense, and Industrial, which are driven by secular trends such as shifting defense priorities, an aging population, increasing energy consumption, and manufacturing automation.

Comparison to Industry Standards

• The document references investor presentations and analyst reports for Sonova Holding AG, Demant A/S, GN Stor Nord A/S, and Amplifon S.p.A., suggesting these are comparable companies in the hearing health solutions market.
• The document references market data from Global Data, Fortune Business Insights, Mordor Intelligence, Yole, and Paumanok, suggesting these are industry standard data sources for market analysis.
• The company's capital deployment strategy targets a return of 200-300 bps above the cost of capital, which is a common benchmark for evaluating investment efficiency.

Stakeholder Impact

• Shareholders can expect continued growth and returns through strategic investments and capital allocation.
• Employees will benefit from the company's focus on high-growth markets and innovation.
• Customers will benefit from customized solutions and high-performance technology.
• Suppliers will benefit from the company's strong financial position and growth prospects.

Next Steps

• Knowles will continue to execute its M&A strategy, focusing on differentiated technology and accretive financial profiles.
• The company will continue to invest in organic growth through capital investments and product innovation.
• Knowles will continue to monitor and manage its capital allocation strategy to drive shareholder returns.

Key Dates

Keywords

Investor Day, Financial Outlook, MedTech, Precision Devices, EBITDA, Revenue, Acquisitions, Growth, Knowles